AstraZeneca (AZN) Pharma and Biotech Sector

  • Latest quote

    5,255.00p (mid)

  • Current Change (%)

    -2.19%

  • Price

    Bid: 5,260.00p

    Offer: 5,262.00p

  • Today

    High: 5,440.00p

    Low: 5,245.40p

  • This year

    High: 5,508.00p

    Low: 4,325.00p

  • Information

    Volume: 1,525,477

    Market Cap: £66616.92M


AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

AstraZeneca RNS Feed

Title Release date
Update: lanabecestat Phase III Alzheimer's trials 07:00 - June 12, 2018
EU APPROVES TAGRISSO FOR 1ST-LINE NSCLC 17:30 - June 8, 2018
Director Declaration 07:00 - June 8, 2018
Total Voting Rights 15:00 - June 1, 2018
Block listing Interim Review 15:00 - June 1, 2018
Director Declaration 11:00 - June 1, 2018
Update on TERRANOVA PIII trial for Fasenra in COPD 07:00 - May 30, 2018
AZ's Imfinzi: significant OS in Stage III nsclc 07:00 - May 25, 2018
US FDA approves Lokelma for adult hyperkalaemia 07:00 - May 21, 2018
AZ regulatory submission in Japan for Forxiga 07:00 - May 21, 2018
Result of AGM 17:30 - May 18, 2018
AZN: Q1 2018 Results 07:00 - May 18, 2018
AstraZeneca update on Fasenra PIII trial in COPD 07:00 - May 11, 2018
EMA approves Lynparza: maintenance ovarian cancer 11:00 - May 8, 2018
AZ and Luye Pharma enter agreement for Seroquel 07:00 - May 8, 2018

NOTE: This is based on 177 open tips for this company


Total Number of Share tips :

327

View all AstraZeneca Tips



Daily share tips delivered straight to your pc, tablet & mobile

Join Free Today